Paz J. Vellanki

United States Food and Drug Administration

Also affiliated with Center for Drug Evaluation and Research, Food and Drug Administration

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “T cell immune deficiency rather than chromosome instability predisposes patients with short telomere syndromes to squamous cancers”.

T cell immune deficiency rather than chromosome instability predisposes patients with short telomere syndromes to squamous cancers

Cancer Cell(2023)10.1016/j.ccell.2023.03.005

N/A

0.639DataRank · unranked

70 citations

Diane A. Flasch, Christine C. Atik, Zoe L. Cosner, Amanda L. Blackford, Wentao Yang +9 more

FDA Approval Summary: Nivolumab with Ipilimumab and Chemotherapy for Metastatic Non–small Cell Lung Cancer, A Collaborative Project Orbis Review

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-4338

N/A

0DataRank · unranked

57 citations

Flora Mulkey, Adnan A. Jaigirdar, Lisa Rodríguez, Yibo Wang, Yuan Xu +14 more